Prenatal Screening for CMV Primary Infection: A Cost-Utility Model

20250 citationsJournal Article

Authors

Georges El Hachem · Green Tide Turbines (United Kingdom)

Christian Renaud · Brno International Business School

Catherine McCarey · Green Tide Turbines (United Kingdom)

Soren Gantt · Brno International Business School

Fatima Kakkar · Green Tide Turbines (United Kingdom)

Marc Sab · Brno International Business School

Thomas G. Poder

Abstract

(Abstracted from BJOG 2025;132:805-815) Approximate 1 in 200 neonates in Canada is born with congenital cytomegalovirus (cCMV). CMV is an infection that can cause neurodevelopmental disability in children, including deafness, visual impairment, or cognitive delay.

Topics & Keywords

Cytomegalovirus and herpesvirus research Neonatal and fetal brain pathology Preterm Birth and Chorioamnionitis

Publication Details

Published in: Obstetrical & Gynecological Survey

Volume 80, Issue 11, pp. 689-691

DOI: 10.1097/01.ogx.0001172288.00818.27

Field-Weighted Citation Impact: 0.00

Command Palette

Prenatal Screening for CMV Primary Infection: A Cost-Utility Model

Authors

Abstract

Topics & Keywords

Publication Details